Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Plans To Use Four Primary Sources For Online Comparative Effectiveness Research Inventory

This article was originally published in The Pink Sheet Daily

Executive Summary

Details regarding the inventory are revealed in a Federal Register notice posted by HHS' Office of the Assistant Secretary for Planning and Evaluation.

You may also be interested in...



HHS Multi-Payer Claims Database For CER Intended As Broad Public-Private Resource

Current plans call for the database to be available to outside researchers by late 2013.

Patient Engagement A Key Part Of PCORI’s “Tier 1” Grants

NEW YORK – Although the list of topics to be researched with “tier 1” grants from the Patient-Centered Outcomes Research Institute will not be finalized until sometime in June, one area that is sure to garner funding opportunities will be finding ways to engage patients as stakeholders.

Patient Engagement A Key Part Of PCORI’s “Tier 1” Grants

NEW YORK – Although the list of topics to be researched with “tier 1” grants from the Patient-Centered Outcomes Research Institute will not be finalized until sometime in June, one area that is sure to garner funding opportunities will be finding ways to engage patients as stakeholders.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel